Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Ppublish 9 citations
PubMed: 36490356 DOI: 10.1182/bloodadvances.2022008404
Evidence of in vivo exogen protein uptake by red blood cells: a putative therapeutic concept.
Blood Adv 7(6):1033-1039
Authors: Laura Hertz, Daniel Flormann, Lutz Birnbaumer, Christian Wagner, Matthias W Laschke, Lars Kaestner
Affiliations
- Theoretical Medicine and Biosciences, Medical Faculty, Saarland University, Homburg, Germany.
- Dynamics of Fluids, Experimental Physics, Saarland University, Saarbruecken, Germany.
- Institute of Biomedical Research (BIOMED), Catholic University of Argentina, Buenos Aires, Argentina.
- Laboratory of Signal Transduction, National Institute of Environmental Health Sciences, Research Triangle Park, NC.
- Physics and Materials Science Research Unit, University of Luxembourg, Luxembourg City, Luxembourg.
- Medical Faculty, Institute for Clinical and Experimental Surgery, Saarland University, Homburg, Germany.
Abstract
For some molecular players in red blood cells (RBCs), the functional indications and molecular evidence are discrepant. One such protein is transient receptor potential channel of canonical subfamily, member 6 (TRPC6). Transcriptome analysis of reticulocytes revealed the presence of TRPC6 in mouse RBCs and its absence in human RBCs. We transfused TRPC6 knockout RBCs into wild-type mice and performed functional tests. We observed the "rescue" of TRPC6 within 10 days; however, the "rescue" was slower in splenectomized mice. The latter finding led us to mimic the mechanical challenge with the cantilever of an atomic force microscope and simultaneously carry out imaging by confocal (3D) microscopy. We observed the strong interaction of RBCs with the opposed surface at around 200 pN and the formation of tethers. The results of both the transfusion experiments and the atomic force spectroscopy suggest mechanically stimulated protein transfer to RBCs as a protein source in the absence of the translational machinery. This protein transfer mechanism has the potential to be utilized in therapeutic contexts, especially for hereditary diseases involving RBCs, such as hereditary xerocytosis or Gárdos channelopathy.
MeSH
Cells, Erythrocytes, Blood, Absenteeism, Blood Cells, Therapeutics, Hematologic Diseases
Cited by
- A "poly-matter network" conception of biological inheritance. Genetica, 2024
- Erythrocytic α-Synuclein in Parkinson's Disease and Progressive Supranuclear Palsy-A Pilot Study. Biomedicines, 2024
- Big Data in Transfusion Medicine and Artificial Intelligence Analysis for Red Blood Cell Quality Control. Transfus Med Hemother, 2023
- The Gárdos Channel and Piezo1 Revisited: Comparison between Reticulocytes and Mature Red Blood Cells. Int J Mol Sci, 2024
- Life destiny of erythrocyte in high altitude erythrocytosis: mechanisms underlying the progression from physiological (moderate) to pathological (excessive) high-altitude erythrocytosis. Front Genet, 2025